SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 232 filers reported holding SEATTLE GENETICS INC in Q4 2015. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,879,000 | +40.0% | 50,480 | +21.6% | 0.03% | +26.9% |
| Q2 2020 | $7,055,000 | +64.4% | 41,518 | +11.6% | 0.03% | +36.8% |
| Q1 2020 | $4,292,000 | +2.5% | 37,207 | +1.5% | 0.02% | +26.7% |
| Q4 2019 | $4,187,000 | +58.4% | 36,640 | +18.3% | 0.02% | +50.0% |
| Q3 2019 | $2,644,000 | +23.3% | 30,962 | -0.1% | 0.01% | +11.1% |
| Q2 2019 | $2,144,000 | -10.2% | 30,984 | -4.9% | 0.01% | -10.0% |
| Q1 2019 | $2,387,000 | +32.0% | 32,586 | +2.1% | 0.01% | +11.1% |
| Q4 2018 | $1,808,000 | -19.0% | 31,901 | +10.2% | 0.01% | -10.0% |
| Q3 2018 | $2,232,000 | +19.5% | 28,952 | +2.8% | 0.01% | +11.1% |
| Q2 2018 | $1,868,000 | +34.4% | 28,150 | +6.0% | 0.01% | +28.6% |
| Q1 2018 | $1,390,000 | -0.9% | 26,562 | +1.4% | 0.01% | 0.0% |
| Q4 2017 | $1,402,000 | -6.0% | 26,207 | -4.4% | 0.01% | -12.5% |
| Q3 2017 | $1,491,000 | -9.0% | 27,404 | -13.5% | 0.01% | -20.0% |
| Q2 2017 | $1,639,000 | -17.5% | 31,693 | +0.3% | 0.01% | -28.6% |
| Q1 2017 | $1,986,000 | +31.9% | 31,602 | +10.7% | 0.01% | +16.7% |
| Q4 2016 | $1,506,000 | +10.2% | 28,549 | +12.8% | 0.01% | +20.0% |
| Q3 2016 | $1,367,000 | +45.3% | 25,307 | +8.6% | 0.01% | +42.9% |
| Q2 2016 | $941,000 | +28.0% | 23,302 | +11.3% | 0.01% | +16.7% |
| Q1 2016 | $735,000 | +12.4% | 20,938 | +43.7% | 0.01% | 0.0% |
| Q4 2015 | $654,000 | +44.4% | 14,568 | +23.9% | 0.01% | +20.0% |
| Q3 2015 | $453,000 | -7.6% | 11,755 | +16.2% | 0.01% | 0.0% |
| Q2 2015 | $490,000 | +56.1% | 10,120 | +19.9% | 0.01% | +25.0% |
| Q3 2014 | $314,000 | -9.0% | 8,442 | -6.5% | 0.00% | -20.0% |
| Q2 2014 | $345,000 | +17.3% | 9,026 | +40.1% | 0.01% | +25.0% |
| Q1 2014 | $294,000 | +15.3% | 6,444 | +0.9% | 0.00% | 0.0% |
| Q4 2013 | $255,000 | -1.9% | 6,385 | +7.6% | 0.00% | -20.0% |
| Q3 2013 | $260,000 | – | 5,935 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |